CPT code 87472 designates a nucleic acid probe test to quantify infection with Bartonella henselae and Bartonella quintana. This molecular diagnostic code captures specialized laboratory testing used in clinical evaluation of suspected Bartonella infection, an important but relatively uncommon vector-borne and zoonotic disease. Accurate identification and quantification can influence clinical management and public health reporting, making this code relevant for hospital and reference laboratory billing nationally. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical context for the test, typical sites of service, and payer coverage considerations. The publication provides benchmarks for utilization and reimbursement patterns when available, notes recent policy updates affecting molecular diagnostics billing, and summarizes common billing practices and documentation expectations. Where input data is not provided, the text notes that data is not available in the input. The content is intended for coding, billing, and laboratory management professionals seeking a national overview of how CPT code 87472 is described and applied in practice.